Figures and data in Extramacrochaetae regulates Notch signaling in the Drosophila eye through non-apoptotic caspase activity

Figures
Tables
Additional files

9 figures, 1 table and 1 additional file

Figures

Figure 1

Download asset Open asset

*Df(3L)H99* recues growth defect of *emc* mutant clones.

(**A–L**) Control and mutant clones in eye and wing imaginal disc were induced at the end of first instar and are associated with sibling twin-spot clones marked by two copies of the GFP marker (brighter gray) that serves as internal control for growth. Clones are labeled by the absence of GFP. (M) *emc H99* clones induced in the Minute background (N) Quantification of the ratio of clone size to twin-spot measured in wing imaginal discs. Geometrical means ± SEM are shown. After log-transformation of clone/twin-spot ratios to ensure normality, one-way ANOVA rejected the null hypothesis that these results are the same (p = 5.72 × 10⁻⁸). The Holm correction for multiple comparison was used to identify significant differences between all pairs of samples. *** denotes highly significant difference from the FRT80 control (p < 0.001), NS denotes no significant difference (p > 0.05). Whereas the clone/twin-spot ratio for *emc* homozygous clones was significantly different from the FRT80 control (p = 5.72 × 10⁻⁶), this was not true for any of the other genotypes (*H99*, p = 0.79; *dronc*, p = 0.906; *emc H99*, p = 0.92; *emc dronc*, p = 0.345). The clone/twin-spot ratio for *emc* homozygous clones was also significantly different from that for *emc H99* or *emc dronc* (p = 4.12 × 10⁻⁶ and p = 0.0177, respectively), whereas *emc H99* and *emc dronc* did not differ significantly from *H99* or *dronc* clones (p = 1 and p = 0.136, respectively). Source data for (N) are provided in Figure 1—source data 1. Genotypes: (**A, C**) *ywhsF;FRT80/[UbiGFP]FRT80*, (**B, D**) *ywhsF;emc^AP6FRT80/[Ubi-GFP]FRT80*, (**E, G**) *ywhsF;droncⁱ²⁹emc^AP6 FRT80/[UbiGFP]FRT80*, (**F, H**) *ywhsF;emc^AP6 Df(3L)H99 FRT80/[UbiGFP]FRT80*, (**I, K**) *ywhsF;droncⁱ²⁹ FRT80/[UbiGFP]FRT80*, (**J, L**) *ywhsF;;Df(3L)H99FRT80/[UbiGFP]FRT80*, (M) *ywhsF; emc^AP6 Df(3L)H99 FRT80/[UbiGFP] M(3)67C FRT80*. N = 10 for each genotype.

Figure 1—source data 1 Clone size source data for Figure 1N.: https://cdn.elifesciences.org/articles/91988/elife-91988-fig1-data1-v1.xlsx
Download elife-91988-fig1-data1-v1.xlsx

Figure 2 with 1 supplement

Download asset Open asset

Morphogenetic furrow progression is affected by cell death pathways.

In all panels, the differentiating neurons are marked by Elav (in blue), and mutant cells are identiﬁed by the absence of GFP expression (in green). (A) The wave of retinal differentiation from posterior to anterior (right to left), marked here by Senseless expression in R8 photoreceptor cells (red) is normal in FRT80 control clones. (B) *emc* null clones lacking GFP show acceleration of retinal differentiation illustrated by yellow arrows (premature differentiation can also continue into wild-type regions ahead of such clones). In addition, ectopic neural differentiation also occurs sporadically anterior to the morphogenetic furrow, and unassociated with it (magenta arrows). (C) In contrast, retinal differentiation proceeds at the same pace in *emc dronc* double mutant clones as in nearby wild-type regions in 75% of the eye discs. (D) *emc H99* double mutants show a stronger suppression of the acceleration of retinal differentiation (compare panel B). Genotypes: (A) *ywhsF;FRT80/[UbiGFP] M(3)67C FRT80*, (B) *ywhsF;emc^AP6FRT80/[Ubi-GFP] M(3)67C FRT80*, (C) *ywhsF;droncⁱ²⁹emc^AP6 FRT80/[UbiGFP] M(3)67C FRT80* (n = 12), (D) *ywhsF;emc^AP6 Df(3L)H99 FRT80/[UbiGFP] M(3)67C FRT80*. N = 8 for each genotype.

Figure 2—figure supplement 1

Download asset Open asset

Morphogenetic furrow progression in *emc* mutant cells.

In eye imaginal discs, normal furrow progression was observed in (A) *dronc^−/−* and (B) *Df(3L)H99* homozygous clones, indicated by Senseless and Elav staining. Homozygous mutant clones of *emc^−/−* (C) lacking GFP expression have no Emc staining (yellow arrowhead) and higher Da (red arrowhead). At the morphogenetic furrow as shown by yellow arrow, Emc expression goes down and Da goes up. Similar results were observed in (D) *dronc^−/− emc^−/−* clones and (E) *emc^−/− Df(3L) H99^−/−* clones confirm that these are *emc* null clones. Genotypes: (A) *ywhsF;droncⁱ²⁹FRT80/[UbiGFP] M(3)67C FRT80*, (B) *ywhsF; Df(3L)H99 FRT80/[UbiGFP] M(3)67C FRT80*, (C) *ywhsF;emc^AP6FRT80/[Ubi-GFP] M(3)67C FRT80*, (D) *ywhsF;droncⁱ²⁹emc^AP6 FRT80/[UbiGFP] M(3)67C FRT80*, (E) *ywhsF;emc^AP6 Df(3L)H99 FRT80/[UbiGFP] M(3)67C FRT80*. N = 4 for each genotype.

Figure 3 with 3 supplements

Download asset Open asset

Diap1 expression in *emc* clones.

In mosaic eye discs with (A) FRT80 clones, there is no difference in Diap1 levels within and outside the clone. However, both (B) *emc* mutant clones and (C) *emc H99* clones show reduced Diap1 levels posterior to the morphogenetic furrow, compared to the heterozygous background. (D) *H99* clones showed similar Diap1 levels, compared to the heterozygous background. (E) Quantification of Diap1 levels in different clone genotypes, compared to the background levels outside the clones. Means ± SEM are shown. Note that our experiments did not generate mosaics of wild-type and Df(3L)H99/+ cells for direct comparison of these genotypes. Statistical significance calculated by two-way ANOVA (****p ≤ 0.0001). Source data for (E) are provided in Figure 3—source data 1. Genotypes: (A) *ywhsF;FRT80/[UbiGFP] M(3)67C FRT80*, (B) *ywhsF;emc^AP6FRT80/[Ubi-GFP] M(3)67C FRT80*, (C) *ywhsF;emc^AP6 Df(3L)H99 FRT80/[UbiGFP] M(3)67C FRT80*, (D) *ywhsF; Df(3L)H99 FRT80/[UbiGFP] M(3)67C FRT80*. N = 6 for each genotype.

Figure 3—source data 1 Anti-Diap1 labeling source data for Figure 3E.: https://cdn.elifesciences.org/articles/91988/elife-91988-fig3-data1-v1.xlsx
Download elife-91988-fig3-data1-v1.xlsx

Figure 3—figure supplement 1

Download asset Open asset

DIAP1 staining in wing disc clones.

In wing discs of emc clones (B) we did not detect changes in Diap1 levels in comparison to control clones (A). Genotypes: (A) *ywhsF;FRT80/[UbiGFP] M(3)67C FRT80*, (B) *ywhsF;emc^AP6FRT80/[Ubi-GFP] M(3)67C FRT80*.

Figure 3—figure supplement 2

Download asset Open asset

Apoptosis and furrow progression.

Representative images of eye imaginal discs stained for senseless. (A) In GMR-DIAP1 eye disc mutant for emc furrow progression is normal and is marked by Senseless staining. Similarly, in GMR-p35 eye disc mutant for emc also show normal furrow progression (B). Representative images of eye imaginal discs with terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. (A) *ywhsF/GMR-DIAP1;emc^AP6FRT80/[Ubi-GFP] M(3)67C FRT80*, (B) *ywhsF/GMR-p35;emc^AP6FRT80/[Ubi-GFP] M(3)67C FRT80*, (C) *ywhsF;FRT80/[UbiGFP] M(3)67C FRT80*, (D) *ywhsF;emc^AP6FRT80/[Ubi-GFP] M(3)67C FRT80*. N = 4 for each genotype.

Figure 3—figure supplement 3

Download asset Open asset

Emc clones show no caspase activity beyond the morphogenetic furrow.

In *pie^EB3* homozygous clones, furrow progression occurs at normal speed marked by Senseless staining in R8 photoreceptors (A). In GMR-p35 eye disc mutant for emc show lack of Dcp1staining (B). In *emc* mutant clones posterior to morphogenetic furrow show lack of Dcp1 staining (D) in comparison to FRT80 clones (C). Genotypes: (A) *ywhsF/+; pie^EB3FRT40/FRT40Alz*, (B) *ywhsF/GMR-p35;;emc^AP6FRT80/[Ubi-GFP] M(3)67C FRT80*, (C) *ywhsF;;FRT80/[UbiGFP] M(3)67C FRT80*, (D) *ywhsF;;emc^AP6FRT80/[Ubi-GFP] M(3)67C FRT80*, (E) *ywhsF;;emc^AP6 Df(3L*)*H99 FRT80/[UbiGFP] M(3)67C FRT80*. N = 4 for each genotype.

Figure 4 with 1 supplement

Download asset Open asset

Wingless and Dpp signaling are not caspase targets.

(A) No reduction in the Wg signaling reporter Fz3-RFP was detectable in emc clones. See Figure 4—figure supplement 1 for Fz3-RFP expression in the wild-type. (B) Retinal differentiation is accelerated in *emc nkd³* double mutant clones like in *emc* clones. Senseless expression in R8 photoreceptor cells and Elav staining in differentiating photoreceptors are shown. (C) p-Mad accumulates around the morphogenetic furrow in eye discs containing control clones (Firth et al., 2010; Vrailas and Moses, 2006). (E) Except for the advanced progression, p-Mad levels were unchanged in *emc* clones. Genotypes: (A) *Fz3-RFP/+; emc^AP6FRT80/[Ubi-GFP] M(3)67C FRT80*, (B) *ywhsF;emc^AP6nkd³FRT80/[Ubi-GFP] M(3)67C FRT80*, (C) *ywhsF;FRT80/[UbiGFP] M(3)67C FRT80*, (D) *ywhsF;emc^AP6FRT80/[Ubi-GFP] M(3)67C FRT80*. N = 8 for each genotype.

Figure 4—figure supplement 1

Download asset Open asset

Fz3-RFP/+ eye disc showing RFP and Elav staining.

N = 3.

Figure 5 with 2 supplements

Download asset Open asset

Ci expression and function in *emc* mutant clones.

(A) Ci is elevated within *emc* mutant cells (yellow arrows). This was also true posterior to the morphogenetic furrow (orange arrow). (B) Higher Ci was also seen in *emc dronc* mutant cells, even when the morphogenetic furrow progressed normally, as indicated by Elav staining. (C) Ci levels were completely normal in *emc H99* clones. (D) *emc* and ci double mutant clones lacking GFP shows accelerated retinal differentiation (blue arrow). Genotypes: (A) *ywhsF;emc^AP6FRT80/[Ubi-GFP] M(3)67C FRT80*, (B) *ywhsF;droncⁱ²⁹emc^AP6 FRT80/[UbiGFP] M(3)67C FRT80*, (C) *ywhsF;emc^AP6 Df(3L)H99 FRT80/[UbiGFP] M(3)67C FRT80*, (D) *ywhsF;emc^AP6FRT80/[Ubi-GFP] ci⁺ M(3)67C FRT80;ci[94]/ci[94]*. N = 8 for each genotype except (D) which has n = 3.

Figure 5—figure supplement 1

Download asset Open asset

Ci155 levels when cell death pathways are blocked.

Representative image of eye imaginal disc in *emc H99* clones in the non-Minute background, showing similar areas inside and outside clones. Genotype: *ywhsF; emc^AP6 Df(3L)H99 FRT80/[UbiGFP]FRT80*. N = 4.

Figure 5—figure supplement 2

Download asset Open asset

Patched staining in emc mutants.

(A) *ywhsF;FRT80/[UbiGFP] M(3)67C FRT80*, (B) *ywhsF;emc^AP6FRT80/[Ubi-GFP] M(3)67C FRT80*, (C) *ywhsF;emc^AP6 Df(3L)H99 FRT80/[UbiGFP] M(3)67C FRT8*.

Figure 6

Download asset Open asset

Notch activity and function in emc mutant clones.

(A) E(spl), an important N target for lateral inhibition, is elevated in the morphogenetic furrow region of *emc* clones (yellow arrows). (B) *emc dronc* clones have normal levels of E(spl) protein. (C) Senseless staining shows a neurogenic phenotype in *psn* mutant clones, due to reduced Notch signaling. Morphogenetic furrow progression is unaffected. (D) A neurogenic phenotype was also observed in *emc psn* clones, along with normal furrow progression. (E) *Su(H)* mutant clones identified by absence of GFP labeling show a strong neurogenic phenotype as well as advanced retinal differentiation (orange arrow) (Li and Baker, 2001). The cell-autonomous effect results in a discontinuity at the borders of *Su(H)* clones, where differentiation outside the clones lags that within clones (orange arrow) Genotypes: (A) *ywhsF;emc^AP6 FRT80/[Ubi-GFP] M(3)67C FRT80*, (B) *ywhsF; droncⁱ²⁹emc^AP6 FRT80/[UbiGFP] M(3)67C FRT80*, (C) *ywhsF/+;psn^V1 FRT80/[Ubi-GFP]M(3)67CFRT80*, (D) *ywhsF/+; emc^AP6 psn^V1 FRT80/[Ubi-GFP]M(3)67CFRT80*, (E) *ywhsF; Su(H)^D47*FRT40/FRT40[UbiGFP]. N = 6 for each genotype.

Figure 7 with 1 supplement

Download asset Open asset

Caspases regulate Delta levels.

(A) Normal levels of Delta protein are seen in FRT80 clones as compared to elevated Delta levels in (B) *emc* clones (arrowheads) whereas that phenotype is reversed in (D) *emc H99* clones. However, as seen in (C), some *dronc emc* clones show intermediate Delta levels, although most resemble wild type. (E) Quantification of Delta levels in different clone genotypes, compared to the background levels outside the clones. Means ± SEM are shown. Significance was determined using one-way Anova with Tukey’s post hoc test. (**p ≤ 0.01, ****p ≤ 0.0001). Source data for (E) are provided in Figure 7—source data 1. Genotypes: (A) *ywhsF;FRT80/[UbiGFP] M(3)67C FRT80*, (B) *ywhsF;emc^AP6FRT80/[Ubi-GFP] M(3)67C FRT80*, (C) *ywhsF;droncⁱ²⁹emc^AP6 FRT80/[UbiGFP] M(3)67C FRT80*, (D) *ywhsF;emc^AP6 Df(3L)H99 FRT80/[UbiGFP]FRT80*. N = 7 for each genotype.

Figure 7—source data 1 Anti-Dl labeling source data for Figure 7E.: https://cdn.elifesciences.org/articles/91988/elife-91988-fig7-data1-v1.xlsx
Download elife-91988-fig7-data1-v1.xlsx

Figure 7—figure supplement 1

Download asset Open asset

Potential caspase sites predicted in the Delta protein.

Like many proteins, Delta has multiple potential caspase cleavage sites, here predicted suing Cascleave 2.0 (Wang et al., 2014). None are high-confidence predictions and only one is in the intracellular domain where caspase access is plausible (position 675, predicted score 0.647). The intracellular domain is required for Delta signaling. Cleavage at position 675 would remove the main ubiquitylation site required for signaling, as well as the binding site for *mindbomb*, so is not anticipated to enhance signaling activity (Daskalaki et al., 2011).

Figure 8

Download asset Open asset

Caspases contribute to R7 photoreceptor and cone cell defects in *emc* mutants.

In all panels, *emc* mutant cells are marked by the absence of GFP expression (in green) and photoreceptor neurons are marked by Elav in blue. (A) Runt (in red) is expressed in R7 and R8 (yellow arrowhead) photoreceptor cells inside and outside the clone in FRT80 controls. (B) Inside *emc* clone, Runt expression is lost from R7 cells, while expression in R8 cells remains unaffected (orange arrowhead). (C) However, inside the *emc H99* clones, Runt is expressed in both R7 and R8 cells. (D) Cut (in red) is expressed in cone cells in FRT80 controls. (E) Inside *emc* clones, cut is delayed. (F) However, inside the *emc H99* clones, cut staining is not delayed. Genotypes: (**A, D**) *ywhsF;FRT80/[UbiGFP] M(3)67C FRT80*, (**B, E**) *ywhsF;emc^AP6FRT80/[Ubi-GFP] M(3)67C FRT80*, (**C, F**) *ywhsF;emc^AP6 Df(3L)H99 FRT80/[UbiGFP] M(3)67C FRT80*. N = 4 for each genotype.

Figure 9

Download asset Open asset

Model of *emc* effects on *Drosophila* eye development.

Loss of *emc* allows Da protein to form homodimers and activate ex transcription, increasing Salvador–Warts–Hippo (SWH) pathway activity. SWH activity reduces DIAP1 expression, thereby derepressing caspase activity. In the eye, non-apoptotic caspase activity increases expression of the Notch ligand Delta. Elevated Delta expression accelerates morphogenetic furrow progression, while cis-inhibiting Notch signaling posterior to the morphogenetic furrow, inhibiting R7 cell specification and cone cell differentiation. In wild-type cells, most Da is likely heterodimerized with either a proneural protein or with Emc protein, and there is no role of caspases in Dl expression.

Tables

Key resources table

Reagent type (species) or resource	Designation	Source or reference	Identifiers	Additional information
Gene (Drosophila melanogaster)	emc	GenBank	FBgn0000575
Genetic reagent (D. melanogaster)	emc [AP6]	PMID:7947322	FBal0051626
Genetic reagent (D. melanogaster)	dronc [i29]	PMID:15800001	FBal0190283
Genetic reagent (D. melanogaster)	Df(3L)H99	PMID:8171319	FBab0022359
Genetic reagent (D. melanogaster)	nkd[3]	PMID:2081466	FBal0013025
Genetic reagent (D. melanogaster)	PBac{y+ w + ci+}VK33	This paper
Genetic reagent (D. melanogaster)	psn[v1]	Bloomington Drosophila Stock Center	FBal0316340 BDSC: 63237
Genetic reagent (D. melanogaster)	Fz3-RFP	PMID:21869817
Genetic reagent (D. melanogaster)	pie[eB3]	PMID:1634999	FBal0032439
Genetic reagent (D. melanogaster)	Su(H)Δ47	PMID:1617730	FBal0103950
Antibody	Emc (Rabbit polyclonal)	Y.N. Jan		(1:8000)
Antibody	Da (Mouse monoclonal)	PMID:3802198		(1:200)
Antibody	GFP (Rat monoclonal)	Nacalai Tesque	Cat #GF090R RRID:AB_2314545	(1:50)
Antibody	GFP (Rabbit polyclonal)	Invitrogen	Cat #A-11122 RRID:AB_221569	(1:500)
Antibody	β-Gal (Mouse monoclonal)	Developmental Studies Hybridoma Bank	Cat #40-1a RRID:AB_528100	(1:100)
Antibody	β-Gal (Rabbit polyclonal)	Cappel (MP Biomedicals)	Cat #55976 RRID:AB_2313707	(1:100)
Antibody	Runt (Guinea pig polyclonal)	PMID:9683745		(1:500)
Antibody	E(spl)bHLH mAb323 (Mouse monoclonal)	PMID:1618155		(1:50)
Antibody	Senseless (Guinea pig polyclonal)	PMID:10975525		(1:500)
Antibody	Cleaved Drosophila Dcp-1 (Rabbit polyclonal)	Cell Signaling Technology	Cat #9578 RRID:AB_2721060	(1:100)
Antibody	DIAP1 (Rabbit polyclonal)	PMID:12021769		(1:50)
Antibody	phospho-Smad1/5 (Rabbit monoclonal)	Cell Signaling Technology	Cat #9516 RRID:AB_491015	(1:100)
Antibody	Delta (Mouse monoclonal)	Developmental Studies Hybridoma Bank	Cat #C594.9B RRID:AB_528194	(1:2000)
Antibody	Cut (Mouse monoclonal)	Developmental Studies Hybridoma Bank	Cat #2B10 RRID:AB_528186	(1:50)
Antibody	Ptc (Mouse monoclonal)	Developmental Studies Hybridoma Bank	Cat #Apa 1 RRID:AB_528441	(1:40)
Antibody	Elav (Rat monoclonal)	Developmental Studies Hybridoma Bank	Cat #7E8A10 RRID:AB_528218	(1:50)
Antibody	Elav (Mouse monoclonal)	Developmental Studies Hybridoma Bank	Cat #9F8A9 RRID:AB_528217	(1:100)
Antibody	Ci (Rat monoclonal)	Developmental Studies Hybridoma Bank	Cat #2A1 RRID:AB_2109711	(1:10)
Antibody	Cy2, Cy3, and Cy5	Jackson ImmunoResearch		(1:200)
Antibody	Alexa 555 (Guinea pig polyclonal)	Invitrogen	Cat #A-21435 RRID:AB_2535856	(1:500)
Recombinant DNA reagent	genomic Ci	PMID:33084577
Commercial assay or kit	ApopTag Red in situ apoptosis detection kit	Millipore Sigma	Cat #S7165
Software	Cascleave 2.0	PMID:24149049